Target Genes of c-MYC and MYCN with Prognostic Power in Neuroblastoma Exhibit Different Expressions during Sympathoadrenal Development

SIMPLE SUMMARY: More than 40% of high-risk neuroblastoma (NB) cases are characterized by aberrations in the transcription factors MYCN and c-MYC. Nevertheless, the developmental stage and mechanisms through which MYCN and c-MYC contribute to the onset and progression of the malignancy are not fully...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Ye, Alzrigat, Mohammad, Rodriguez-Garcia, Aida, Wang, Xueyao, Bexelius, Tomas Sjöberg, Johnsen, John Inge, Arsenian-Henriksson, Marie, Liaño-Pons, Judit, Bedoya-Reina, Oscar C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527308/
https://www.ncbi.nlm.nih.gov/pubmed/37760568
http://dx.doi.org/10.3390/cancers15184599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527308/
https://www.ncbi.nlm.nih.gov/pubmed/37760568
http://dx.doi.org/10.3390/cancers15184599

Ejemplares similares